The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Chitosan-based delivery systems for protein therapeutics and antigens
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel crosslinking methods to design hydrogels
Hennink, W. E., & van Nostrum, C. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00240-x · Cited by 1,962
Self-citationNovel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency
Mao, H.-Q., Roy, K., Troung-Le, V. L., Janes, K. A., Lin, K. Y., Wang, Y., August, J. T., & Leong, K. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00361-8 · Cited by 1,228
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Cationic Polymer Based Gene Delivery Systems
De Smedt, S. C., Demeester, J., & Hennink, W. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007548826495 · Cited by 884
Self-citationHuang, M., Khor, E., & Lim, L.-Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016249.52831.a5 · Cited by 853
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Chitosan: A Unique Polysaccharide for Drug Delivery
Felt, O., Buri, P., & Gurny, R. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809089942 · Cited by 769
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 765
Chitosan as a novel nasal delivery system for vaccines
Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A. N., & Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00171-5 · Cited by 755
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Synthesis and antibacterial activities of quaternary ammonium salt of chitosan
Jia, Z., shen, D., & Xu, W. (2001) · Carbohydrate Research · doi:10.1016/s0008-6215(01)00112-4 · Cited by 681
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 629
Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin
Bhumkar, D. R., Joshi, H. M., Sastry, M., & Pokharkar, V. B. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9257-9 · Cited by 624
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Self-citationPathogen recognition and development of particulate vaccines: Does size matter?
Xiang, S. D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P. L., & Plebanski, M. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.016 · Cited by 602
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
Schipper, N. G. M., Olsson, S., Hoogstraate, J. A., deBoer, A. G., Vårum, K. M., & Artursson, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012160102740 · Cited by 586
The Lungs as a Portal of Entry for Systemic Drug Delivery
Patton, J. S., Fishburn, C. S., & Weers, J. G. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-049ta · Cited by 563
Allometric Relationships of Cell Numbers and Size in the Mammalian Lung
Stone, K. C., Mercer, R. R., Gehr, P., Stockstill, B., & Crapo, J. D. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/6.2.235 · Cited by 550
GIUDICE, E., & CAMPBELL, J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.003 · Cited by 496
Epithelial M Cells: Differentiation and Function
Kraehenbuhl, J.-P., & Neutra, M. R. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.301 · Cited by 474
Microencapsulated chitosan nanoparticles for lung protein delivery
Grenha, A., Seijo, B., & Remuñán-López, C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.009 · Cited by 469
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
Antimicrobial properties of N-carboxybutyl chitosan
Muzzarelli, R., Tarsi, R., Filippini, O., Giovanetti, E., Biagini, G., & Varaldo, P. E. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.2019 · Cited by 436
Preparation and NMR characterization of highly substitutedN-trimethyl chitosan chloride
Sieval, A. B., Thanou, M., Kotze´, A. F., Verhoef, J. C., Brussee, J., & Junginger, H. E. (1998) · Carbohydrate Polymers · doi:10.1016/s0144-8617(98)00009-5 · Cited by 432
Bernkop-Schnürch, A. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00271-0 · Cited by 426
Amidi, M., Romeijn, S. G., Borchard, G., Junginger, H. E., Hennink, W. E., & Jiskoot, W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.014 · Cited by 415
Self-citationImmunological activity of chitin and its derivatives
Nishimura, K., Nishimura, S., Nishi, N., Saiki, I., Tokura, S., & Azuma, I. (1984) · Vaccine · doi:10.1016/s0264-410x(98)90039-1 · Cited by 394
Chitin regulation of immune responses: an old molecule with new roles
Lee, C. G., Da Silva, C. A., Lee, J.-Y., Hartl, D., & Elias, J. A. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.10.002 · Cited by 393
Borchard, G., Lueβen, H. L., de Boer, A. G., Verhoef, J. C., Lehr, C.-M., & Junginger, H. E. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00146-8 · Cited by 393
Trimethylated chitosans as non-viral gene delivery vectors: Cytotoxicity and transfection efficiency
Kean, T., Roth, S., & Thanou, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.001 · Cited by 389
Yamamoto, H., Kuno, Y., Sugimoto, S., Takeuchi, H., & Kawashima, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.010 · Cited by 389
Evaluation of the clearance characteristics of bioadhesive systems in humans
Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S., & Illum, L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00367-6 · Cited by 360
Bronchial lymphoid tissue. I. Morphologic characteristics.
Bienenstock, J., Johnston, N., & Perey, D. Y. E. (1973) · PubMed · Cited by 341
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Formation of microparticulate protein powder using a supercritical fluid antisolvent
Yeo, S., Lim, G., Debendetti, P. G., & Bernstein, H. (1993) · Biotechnology and Bioengineering · doi:10.1002/bit.260410308 · Cited by 305
Roldo, M., Hornof, M., Caliceti, P., & Bernkop‐Schnürch, A. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00157-7 · Cited by 292
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
ALPAR, H., SOMAVARAPU, S., ATUAH, K., & BRAMWELL, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.004 · Cited by 287
Shibata, Y., Metzger, W. J., & Myrvik, Q. N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2462 · Cited by 284
Mao, S., Shuai, X., Unger, F., Wittmar, M., Xie, X., & Kissel, T. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.036 · Cited by 281
van der Lubben, I. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00231-3 · Cited by 280
Chitin Is a Size-Dependent Regulator of Macrophage TNF and IL-10 Production
Da Silva, C. A., Chalouni, C., Williams, A., Hartl, D., Lee, C. G., & Elias, J. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802113 · Cited by 279
Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00162-4 · Cited by 274
van der Merwe, S. M., Verhoef, J. C., Verheijden, J. H. M., Kotzé, A. F., & Junginger, H. E. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.023 · Cited by 260
Haidar, Z. S., Hamdy, R. C., & Tabrizian, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.012 · Cited by 260
Development and characterization of new insulin containing polysaccharide nanoparticles
Sarmento, B., Ribeiro, A., Veiga, F., & Ferreira, D. (2006) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2006.09.012 · Cited by 256
Amidi, M., Romeijn, S. G., Verhoef, J. C., Junginger, H. E., Bungener, L., Huckriede, A., Crommelin, D. J. A., & Jiskoot, W. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.06.086 · Cited by 247
Self-citationKotzé, A. R., Lueβen, H. L., de Leeuw, B. J., de Boer, B. G., Verhoef, J. C., & Junginger, H. E. (1997) · Pharmaceutical Research · doi:10.1023/a:1012106907708 · Cited by 245
TLR-2 and IL-17A in Chitin-Induced Macrophage Activation and Acute Inflammation
Da Silva, C. A., Hartl, D., Liu, W., Lee, C. G., & Elias, J. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4279 · Cited by 245
Nanoparticulate Systems for Nasal Delivery of Drugs: A Real Improvement over Simple Systems?
Illum, L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20718 · Cited by 237
Polysaccharide-Based Polyelectrolyte Complex Nanoparticles from Chitosan, Heparin, and Hyaluronan
Boddohi, S., Moore, N., Johnson, P. A., & Kipper, M. J. (2009) · Biomacromolecules · doi:10.1021/bm801513e · Cited by 236
Pharmacological activity of peroral chitosan–insulin nanoparticles in diabetic rats
Ma, Z., Lim, T. M., & Lim, L.-Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.025 · Cited by 231
Gallagher, P. M., Coffey, M. P., Krukonis, V. J., & Klasutis, N. (1989) · ACS Symposium Series · doi:10.1021/bk-1989-0406.ch022 · Cited by 231
Tschernig, T., & Pabst, R. (2000) · Pathobiology · doi:10.1159/000028109 · Cited by 228
Kim, J.-H., Kim, Y.-S., Park, K., Kang, E., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Chi, D. Y., Park, R.-W., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.038 · Cited by 228
SADEGHI, A., DORKOOSH, F., AVADI, M., WEINHOLD, M., BAYAT, A., DELIE, F., GURNY, R., LARIJANI, B., RAFIEETEHRANI, M., & JUNGINGER, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.004 · Cited by 223
Cyclodextrins in nasal drug delivery
Merkus, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00054-4 · Cited by 221
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro
Grenha, A., Grainger, C. I., Dailey, L. A., Seijo, B., Martin, G. P., Remuñán-López, C., & Forbes, B. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.008 · Cited by 219
Xu, Y., Du, Y., Huang, R., & Gao, L. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00408-3 · Cited by 217
Verheul, R. J., Amidi, M., van der Wal, S., van Riet, E., Jiskoot, W., & Hennink, W. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.05.026 · Cited by 206
Self-citationSelf-Assembled Polyelectrolyte Nanocomplexes between Chitosan Derivatives and Insulin
Mao, S., Bakowsky, U., Jintapattanakit, A., & Kissel, T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20520 · Cited by 205
Lin, Y.-H., Chung, C.-K., Chen, C.-T., Liang, H.-F., Chen, S.-C., & Sung, H.-W. (2005) · Biomacromolecules · doi:10.1021/bm049312a · Cited by 200
Bronchus‐ and nasal‐associated lymphoid tissues
Bienenstock, J., & McDermott, M. R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00299.x · Cited by 197
Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles
ZHANG, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.009 · Cited by 197
Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system
Jameela, S. R., Kumary, T. V., Lal, A. V., & Jayakrishnan, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00187-9 · Cited by 196
JAGANATHAN, K., & VYAS, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.011 · Cited by 196
Bivas-Benita, M., van Meijgaarden, K. E., Franken, K. L. M. C., Junginger, H. E., Borchard, G., Ottenhoff, T. H. M., & Geluk, A. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.09.044 · Cited by 195
Effective nasal influenza vaccine delivery using chitosan
Read, R. C., Naylor, S. C., Potter, C. W., Bond, J., Jabbal-Gill, I., Fisher, A., Illum, L., & Jennings, R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.021 · Cited by 194
Kotzé, A. F., Lueßen, H. L., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00016-5 · Cited by 187
Sayın, B., Somavarapu, S., Li, X. W., Thanou, M., Sesardic, D., Alpar, H. O., & Şenel, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.029 · Cited by 178
Lueßen, H. L., Verhoef, J. C., Borchard, G., Lehr, C., de Boer, A. G., & Junginger, H. E. (1995) · Pharmaceutical Research · doi:10.1023/a:1016213405081 · Cited by 175
Mastrobattista, E., Koning, G. A., van Bloois, L., Filipe, A. C. S., Jiskoot, W., & Storm, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200429200 · Cited by 173
Self-citationClearance characteristics of chitosan based formulations in the sheep nasal cavity
Soane, R. J., Hinchcliffe, M., Davis, S. S., & Illum, L. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00602-0 · Cited by 172
Bronchial lymphoid tissue. II. Functional characterisitics.
Bienenstock, J., Johnston, N., & Perey, D. Y. E. (1973) · PubMed · Cited by 169
Preparation of alginate coated chitosan microparticles for vaccine delivery
Li, X., Kong, X., Shi, S., Zheng, X., Guo, G., Wei, Y., & Qian, Z. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-89 · Cited by 167
In vitro evaluation of the viscoelastic properties of chitosan–thioglycolic acid conjugates
Hornof, M. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00162-5 · Cited by 167
Shibata, Y., Foster, L. A., Bradfield, J. F., & Myrvik, Q. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1314 · Cited by 167
Grenha, A., Remuñán-López, C., Carvalho, E. L. S., & Seijo, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.10.017 · Cited by 166
Mao, S., Germershaus, O., Fischer, D., Linn, T., Schnepf, R., & Kissel, T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8175-y · Cited by 164
Xia, W., Pinto, C. E., & Kradin, R. L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1275 · Cited by 163
Stimulation of cytokine production in mice using deacetylated chitin
Nishimura, K., Ishihara, C., Ukei, S., Tokura, S., & Azuma, I. (1986) · Vaccine · doi:10.1016/0264-410x(86)90002-2 · Cited by 162
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin
GARCIAFUENTES, M., TORRES, D., & ALONSO, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.030 · Cited by 161
Jiang, H.-L., Kang, M. L., Quan, J.-S., Kang, S. G., Akaike, T., Yoo, H. S., & Cho, C.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.025 · Cited by 161
Kotzé, A. F., Thanou, M. M., Lueben, H. L., De Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980233c · Cited by 158
Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., de Sousa, A., Borchard, G., & Junginger, H. E. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.019 · Cited by 158
Adjuvant activity of chitin derivatives in mice and guinea-pigs
Nishimura, K., Nishimura, S., Nishi, N., et al. (1985) · Vaccine · doi:10.1016/0264-410x(85)90127-6 · Cited by 156
Elvassore, N., Bertucco, A., & Caliceti, P. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1113 · Cited by 155
Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, Oxantrazole
Hassan, E. E., Parish, R. C., & Gallo, J. M. (1992) · Pharmaceutical Research · doi:10.1023/a:1015803321609 · Cited by 149
Carrier-based strategies for targeting protein and peptide drugs to the lungs
Cryan, S. (2005) · The AAPS Journal · doi:10.1208/aapsj070104 · Cited by 149
Bienenstock, J., Rudzik, O., Clancy, R. L., & Perey, D. Y. E. (1974) · Springer eBooks · doi:10.1007/978-1-4613-4550-3_6 · Cited by 148
Chitosan‐NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin
Wang, X., Zheng, C., Wu, Z., Teng, D., Zhang, X., Wang, Z., & Li, C. (2008) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31161 · Cited by 147
Mi, F., Wu, Y.-Y., Lin, Y.-H., Sonaje, K., Ho, Y., Chen, C.-T., Juang, J.-H., & Sung, H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800076n · Cited by 146
Thanou, M., Verhoef, J. C., Marbach, P., & Junginger, H. E. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200007)89:7<951::aid-jps13>3.0.co;2-1 · Cited by 145
Thanou, M., Florea, B. I., Langemeÿer, M. W. E., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007558206506 · Cited by 145
Phase Behavioral Effects on Particle Formation Processes Using Supercritical Fluids
Palakodaty, S., & York, P. (1999) · Pharmaceutical Research · doi:10.1023/a:1011957512347 · Cited by 144
Sandri, G., Rossi, S., Bonferoni, M. C., Ferrari, F., Zambito, Y., Colo, G. D., & Caramella, C. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.017 · Cited by 143
A Contiguous Network of Dendritic Antigen-Presenting Cells within the Respiratory Epithelium
Holt, P. G., Schon-Hegrad, M. A., Oliver, J., Holt, B. J., & McMenamin, P. G. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235107 · Cited by 143
Wang, L.-Y., Gu, Y., Zhou, Q.-Z., Ma, G., Wan, Y., & Su, Z. G. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.05.006 · Cited by 143
Teijeiro‐Osorio, D., Remuñán‐López, C., & Alonso, M. J. (2008) · Biomacromolecules · doi:10.1021/bm800975j · Cited by 141
Sandri, G., Bonferoni, M. C., Rossi, S., et al. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.07.016 · Cited by 141
Nagamoto, T., Hattori, Y., Takayama, K., & Maitani, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022414.17183.58 · Cited by 136
A novel bioadhesive intranasal delivery system for inactivated influenza vaccines
Singh, M., Briones, M., & O’Hagan, D. T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00330-8 · Cited by 135
Hamman, J. H., Stander, M. W., & Kotzé, A. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00914-0 · Cited by 132
The role of M cells in mucosal immunity
Hathaway, L. J., & Kraehenbuhl*, J.-P. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000693 · Cited by 131
Macromolecules as safe penetration enhancers for hydrophilic drugs—a fiction?
Junginger, H. E., & Verhoef, J. C. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00100-x · Cited by 124
Ye, S., Wang, C., Liu, X., Tong, Z., Ren, B., & Zeng, F. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.015 · Cited by 123
Jintapattanakit, A., Mao, S., Kissel, T., & Junyaprasert, V. B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.002 · Cited by 122
Polyelectrolyte Complexes Stabilize and Controllably Release Vascular Endothelial Growth Factor
Huang, M., Vitharana, S. N., Peek, L. J., Coop, T., & Berkland, C. J. (2007) · Biomacromolecules · doi:10.1021/bm061211k · Cited by 122
Monodisperse Chitosan Microspheres with Interesting Structures for Protein Drug Delivery
Wei, W., Yuan, L., Hu, G., Wang, L.-Y., Wu, J., Hu, X. F., Su, Z. G., & Ma, G. (2008) · Advanced Materials · doi:10.1002/adma.200702663 · Cited by 122
Witschi, C., & Mrsny, R. (1999) · Pharmaceutical Research · doi:10.1023/a:1018869601502 · Cited by 121
Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers
Chen, F., Zhang, Z., & Huang, Y. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.027 · Cited by 117
Almeida, A. J., & Alpar, H. O. (1996) · Journal of drug targeting · doi:10.3109/10611869609015965 · Cited by 117
Chopra, S., Mahdi, S., Kaur, J., Iqbal, Z., Talegaonkar, S., & Ahmad, F. J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0002 · Cited by 114
Stabilization of proteins in dry powder formulations using supercritical fluid technology
Jovanović, N., Bouchard, A., Hofland, G. W., Witkamp, G.-J., Crommelin, D. J. A., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048185.09483.e7 · Cited by 111
Self-citationVerheul, R. J., Amidi, M., van Steenbergen, M. J., van Riet, E., Jiskoot, W., & Hennink, W. E. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.013 · Cited by 109
Self-citationImmunological Risk of Injectable Drug Delivery Systems
Jiskoot, W., van Schie, R. M., Carstens, M. G., & Schellekens, H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9855-9 · Cited by 107
Self-citationSivadas, N., O’Rourke, D., Tobin, A., Buckley, V., Ramtoola, Z., Kelly, J. G., Hickey, A. J., & Cryan, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.024 · Cited by 106
Okamoto, H., Nishida, S., Todo, H., Sakakura, Y., Iida, K., & Danjo, K. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10285 · Cited by 105
Thanou, M., Verhoef, J. C., Romeijn, S. G., Nagelkerke, J. F., Merkus, F. W. H. M., & Junginger, H. E. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00126-x · Cited by 104
Hamman, J. H., Schultz, C. M., & Kotzé, A. F. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120016724 · Cited by 102
Strong, P., Clark, H. W., & Reid, K. B. M. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01551.x · Cited by 101
Alonso-Sande, M., Cuña, M., Remuñán‐López, C., et al. (2006) · Macromolecules · doi:10.1021/ma060230j · Cited by 100
Chitosan Nanoparticle-Loaded Mannitol Microspheres: Structure and Surface Characterization
Grenha, A., Seijo, B., Serra, C., & Remuñán‐López, C. (2007) · Biomacromolecules · doi:10.1021/bm061131g · Cited by 99
Boonyo, W., Junginger, H. E., Waranuch, N., Polnok, A., & Pitaksuteepong, T. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.025 · Cited by 98
Reverchon, E., Daghero, J., Marrone, C., Mattea, M. A., & Poletto, M. (1999) · Industrial & Engineering Chemistry Research · doi:10.1021/ie990015+ · Cited by 98
M cells at locations outside the gut
Gebert, A., & Pabst, R. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0172 · Cited by 97
Effects of Different N-Trimethyl Chitosans on In Vitro/In Vivo Ofloxacin Transcorneal Permeation
Colo, G. D., Burgalassi, S., Zambito, Y., Monti, D., & Chetoni, P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20197 · Cited by 97
Sun, Y. P., & Wan, A. (2007) · Journal of Applied Polymer Science · doi:10.1002/app.26038 · Cited by 96
Jones, A. T., Gumbleton, M., & Duncan, R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.002 · Cited by 96
Kotzé, A. F., Thanou, M. M., Lueßen, H. L., de Boer, (. G., Verhoef, J. C., & Junginger, H. E. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00006-5 · Cited by 90
Zhu, S., Qian, F., Zhang, Y., Tang, C., & Yin, C. (2007) · European Polymer Journal · doi:10.1016/j.eurpolymj.2007.03.042 · Cited by 87
Dendritic Cells in the Respiratory Tract
Holt, P. G., Schon-Hegrad, M. A., & McMenamin, P. G. (1990) · International Reviews of Immunology · doi:10.3109/08830189009056625 · Cited by 86
Chen, C.-L., Wang, Y., Liu, C.-F., & Wang, J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.023 · Cited by 86
Inhaled insulin for diabetes mellitus
Mandal, T. K. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040249 · Cited by 84
Fischer, S., Allmen, E. U.-V., Waeckerle‐Men, Y., Groettrup, M., Merkle, H. P., & Gander, B. A. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.10.034 · Cited by 80
Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs
Thanou, M., Verhoef, J. C., Verheijden, J. H. M., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011092613951 · Cited by 79
PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release
Zhang, X. G., Teng, D., Wu, Z., Wang, X., Wang, Z., Yu, D., & Li, C. X. (2008) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-008-3500-8 · Cited by 78
Shibata, Y., Honda, I., Justice, J. P., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6123-6130.2001 · Cited by 78
Kang, M. L., Jiang, H., Kang, S., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.038 · Cited by 77
A morphologic study of rabbit bronchial lymphoid aggregates and lymphoepithelium.
Bienenstock, J., & Johnston, N. (1976) · PubMed · Cited by 72
Permeability of Peptides and Proteins in Human Cultured Alveolar A549 Cell Monolayer
Kobayashi, S., Kondo, S., & Juni, K. (1995) · Pharmaceutical Research · doi:10.1023/a:1016295406473 · Cited by 62
van der Merwe, S. M., Verhoef, J. C., Kotzé, A. F., & Junginger, H. E. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00152-8 · Cited by 62
Amidi, M., Pellikaan, H. C., Hirschberg, H. J. H. B., de Boer, A. H., Crommelin, D. J. A., Hennink, W. E., Kersten, G. F. A., & Jiskoot, W. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.064 · Cited by 60
Self-citationZhu, B. D., Qie, Y. Q., Wang, J. L., Zhang, Y., Wang, Q. Z., Xu, Y., & Wang, H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.028 · Cited by 54
Hagenaars, N., Mastrobattista, E., Verheul, R. J., Mooren, I., Glansbeek, H. L., Heldens, J. G. M., van den Bosch, H., & Jiskoot, W. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9845-y · Cited by 54
Self-citationThe effect of the nasal cycle on mucociliary clearance
Soane, R. J., Carney, A. S., Jones, N. S., Frier, M., Perkins, A. C., Davis, S. S., & Illum, L. (2001) · Clinical Otolaryngology · doi:10.1046/j.1365-2273.2001.00423.x · Cited by 54
HERITAGE, Brook, M. A., UNDERDOWN, & McDermott (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00420.x · Cited by 51
Florindo, H. F., Pandit, S. S., Gonçalves, L., Alpar, H. O., & Almeida, A. J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.074 · Cited by 46
Controlled Insulin Release from Chitosan Microparticles
Bugamelli, F., Raggi, M. A., Orienti, I., & Zecchi, V. (1998) · Archiv der Pharmazie · Cited by 42
Holappa, J., Nevalainen, T., Soininen, P., Elomaa, M. A., Safin, R., Másson, M., & Järvinen, T. (2005) · Biomacromolecules · doi:10.1021/bm049372g · Cited by 41
Amidi, M., Krudys, K. M., Snel, C. J., Crommelin, D. J. A., Pasqua, O. E. D., Hennink, W. E., & Jiskoot, W. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.019 · Cited by 39
Self-citationEncapsulation of adenoviral vectors into chitosan–bile salt microparticles for mucosal vaccination
Lameiro, M. H., Malpique, R., Silva, A. C., Alves, P. M., & Melo, E. C. C. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.04.030 · Cited by 39
Intranasal toxicity of selected absorption enhancers.
Haffejee, N., du Plessis, J., Müller, D. G., Schultz, C., Kotzé, A. F., & Goosen, C. (2001) · PubMed · Cited by 39
Claassen, E., Thepen, T., Hoeben, K., Brevé, J. J. P., & Kraal, G. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2930-9_51 · Cited by 36
Pandit, S., Cevher, E., Zariwala, M. G., Somavarapu, S., & Alpar, H. O. (2007) · Journal of Microencapsulation · doi:10.1080/02652040701443700 · Cited by 35
Gallagher, P. M. (1989) · ACS symposium series · Cited by 35
Strategies for cytosolic delivery of liposomal macromolecules
Fretz, M. M., Mastrobattista, E., Koning, G. A., Jiskoot, W., & Storm, G. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.040 · Cited by 34
Self-citationChen, Y., Siddalingappa, B., Chan, P. H. H., & Benson, H. A. (2008) · Biopolymers · doi:10.1002/bip.21055 · Cited by 34
Retained integrity of protein encapsulated in spray-dried chitosan microparticles
Kusonwiriyawong, C., Pichayakorn, W., Lipipun, V., & Ritthidej, G. C. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802190937 · Cited by 29
Bourbouze, R., Raffi, F., Dameron, G., et al. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90110-x · Cited by 27
Research on thymopentin loaded oralN-trimethyl chitosan nanoparticles
Yuan, X.-J., Zhang, Z., Song, Q.-G., & He, Q. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02974081 · Cited by 8
Low molecular weight quaternised chitosan (I): synthesis and characterisation.
Snyman, D., Govender, T., & Kotzé, A. F. (2003) · PubMed · Cited by 8
Cited by
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Hydrogels for Protein Delivery
Vermonden, T., Censi, R., & Hennink, W. E. (2012) · Chemical Reviews · doi:10.1021/cr200157d · Cited by 1,091
Self-citationFan, W., Yan, W., Xu, Z., & Ni, H. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.09.042 · Cited by 929
Liu, H., Wang, C., Li, C., Qin, Y., Wang, Z., Yang, F., Li, Z., & Wang, J. (2018) · RSC Advances · doi:10.1039/c7ra13510f · Cited by 915
Ahmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Metadata
- Authors
- Amidi, M., Mastrobattista, E., Jiskoot, W., & Hennink, W. E.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 62
- Issue
- 1
- Pages
- 59-82
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2154828915
- Cited by
- 620
- References
- 169
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.